CTLA4 is associated with susceptibility to multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Neuroimmunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0165-5728(02)00395-8PMID 12507781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.

  2002cited by this paper
• Score tests for association between traits and haplotypes when linkage phase is ambiguous.

  2002cited by this paper
• Induction of Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Restricts Clonal Expansion of Helper T Cells

  2001cited by this paper
• CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

  2001cited by this paper
• Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis.

  2001cited by this paper
• CTLA4 in multiple sclerosis.: Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese

  2001cited by this paper
• Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis

  2000cited by this paper
• Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population

  2000cited by this paper
• The CTLA-4 gene is associated with multiple sclerosis.

  1999influential reference
• A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission.

  1999cited by this paper
• CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.

  1999cited by this paper
• CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.

  1999cited by this paper
• Genetic association of Ctla-4 to myasthenia gravis with thymoma.

  1998cited by this paper
• The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen.

  1998cited by this paper
• Major histocompatibility complex class II alleles and the course and outcome of MS

  1998cited by this paper
• CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.

  1998cited by this paper
• CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis.

  1998cited by this paper
• Expression and function of CTLA-4 in Th1 and Th2 cells.

  1998cited by this paper
• Genomewide scan of multiple sclerosis in Finnish multiplex families.

  1997cited by this paper
• Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis

  1997cited by this paper
• The emerging role of CTLA-4 as an immune attenuator.

  1997cited by this paper
• Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.

  1997cited by this paper
• Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

  1997cited by this paper
• A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

  1996cited by this paper
• CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

  1996cited by this paper
• A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex

  1996cited by this paper
• The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry.

  1996cited by this paper
• The Future of Genetic Studies of Complex Human Diseases

  1996cited by this paper
• A full genome search in multiple sclerosis

  1996cited by this paper
• CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.

  1995cited by this paper
• Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

  1995cited by this paper
• CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system.

  1995cited by this paper
• Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP.

  1994cited by this paper
• Impairment, disability, and handicap in multiple sclerosis

  1994cited by this paper
• Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

  1993cited by this paper
• Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

  1993cited by this paper
• Diagnostic criteria for multiple sclerosis research involving multiply affected families.

  1991cited by this paper
• Estimating the population attributable risk for multiple risk factors using case-control data.

  1985cited by this paper

• Role of RNA Alternative Splicing in T Cell Function and Disease

  2023cites this paper
• The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis

  2022cites this paper
• Association of CTLA-4 (+49A/G) polymorphism and susceptibility of developing rheumatoid arthritis in an Iraqi Arab population

  2022cites this paper
• Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions

  2021cites this paper
• Association between single nucleotide polymorphisms rs12722489 and multiple sclerosis in Iranian patients with multiple sclerosis

  2020cites this paper
• CTLA-4: From mechanism to autoimmune therapy.

  2020cites this paper
• Some Common SNPs of the T-Cell Homeostasis-Related Genes Are Associated with Multiple Sclerosis, but Not with the Clinical Manifestations of the Disease, in the Polish Population

  2020cites this paper
• The role of immune regulatory molecules in multiple sclerosis.

  2019cites this paper
• Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression.

  2019cites this paper
• Structure Based Screening for Inhibitory Therapeutics of CTLA-4 Unveiled New Insights About Biology of ACTH

  2019cites this paper
• Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis

  2016cites this paper
• Lack Evidence Between CTLA-4 Gene Polymorphisms Among Rheumatoid Arthritis Patients

  2016cites this paper
• The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular Differentiation

  2015cites this paper
• Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.

  2015cites this paper
• CTLA-4 Gene and the Susceptibility of Multiple Sclerosis: An Updated Meta-analysis Study Including 12,916 Cases and 15,455 Controls

  2014cites this paper
• Genetics of primary progressive multiple sclerosis.

  2014influential citation
• CTLA-4 +49 A/G and −318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis

  2013influential citation
• Targeting the B7 Family of Co-Stimulatory Molecules

  2012cites this paper
• Immune checkpoints in central nervous system autoimmunity

  2012cites this paper
• The impact of rs231775 (+49AG) CTLA4 gene polymorphism on transplanted kidney function.

  2012cites this paper
• CTLA‐4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients

  2011influential citation
• Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population

  2011cites this paper
• Multiple sclerosis as a polygenic disease: An update

  2010cites this paper
• Clinical immunological and immunogenetical aspects of neurological diseases.

  2010cites this paper
• Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis

  2010cites this paper
• CTLA-4 gene polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis.

  2010cites this paper
• Alternative splicing in multiple sclerosis and other autoimmune diseases

  2010cites this paper
• ACADEMIC DISSERTATIONS FROM THE FINNISH RED CROSS BLOOD SERVICE NUMBER 54

  2009cites this paper
• Molecular mechanisms of T‐cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy

  2009cites this paper
• The CTLA‐4 gene polymorphisms are associated with CTLA‐4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

  2009cites this paper
• Mouse models of autoimmune diseases.

  2009cites this paper
• Cross-Linking of CD80 on CD4+ T Cells Activates a Calcium-Dependent Signaling Pathway1

  2009cites this paper
• Genetics of T cell co-stimulatory receptors -CD28, CTLA4, ICOS and PDCD1 in immunity and transplantation

  2009cites this paper
• Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis.

  2009cites this paper
• CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis

  2009cites this paper
• Gene expression and variation in multiple sclerosis.

  2009cites this paper
• This information is current as Pathway Activates a Calcium-Dependent Signaling T Cells + Cross-Linking of CD 80 on CD 4

  2008cites this paper
• CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.

  2008cites this paper
• Genetics and Natural History of Multiple Sclerosis

  2008cites this paper
• Cytotoxic T lymphocyte associated antigen‐4 exon 1 A/G polymorphism in Iranian patients with multiple sclerosis

  2008cites this paper
• Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland

  2008cites this paper
• Lack of Association between Promoter Gene Polymorphism (-318 C/T) and Multiple Sclerosis in Iranian Population

  2008cites this paper
• Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.

  2007cites this paper
• CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.

  2007cites this paper
• No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis

  2007influential citation
• Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications

  2007cites this paper
• The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis

  2007cites this paper
• Immunopathological mechanisms in multiple sclerosis

  2006cites this paper
• CD4+ T Cell Expressed CD80 Regulates Central Nervous System Effector Function and Survival during Experimental Autoimmune Encephalomyelitis1

  2006cites this paper
• No evidence of a significant role for CTLA-4 in multiple sclerosis.

  2006influential citation
• Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.

  2006cites this paper
• CTLA‐4 gene polymorphisms and natural soluble CTLA‐4 protein in psoriasis vulgaris

  2006cites this paper
• Non-HLA associations with autoimmune diseases.

  2006cites this paper
• Distribution of CTLA-4 Polymorphisms in Allergic Asthma

  2006cites this paper
• Kapitel 10 – Genetische und molekularbiologische Untersuchungen

  2006cites this paper
• Short communication Association of polymorphisms in CTLA-4, IL-1ra and IL-1β genes with multiple sclerosis in Serbian population

  2006cites this paper
• CD4 T Cell Expressed CD80 Regulates Central Nervous System Effector Function and Survival during Experimental Autoimmune Encephalomyelitis

  2006cites this paper
• Identification of genetic factors contributing to disease susceptibility in Multiple Sclerosis

  2006cites this paper
• CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese.

  2005cites this paper
• Variants of the CTLA4 gene that segregate with autoimmune diseases are not associated with endometriosis.

  2005cites this paper
• CHAPTER 3 – THE IMMUNE SYSTEM AND THE INFLAMMATORY RESPONSE

  2005cites this paper
• Multiple Sclerosis, Genetics, and Autoimmunity

  2005cites this paper
• The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.

  2005cites this paper
• Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population

  2005cites this paper
• Identification of genetic factors contributing to disease susceptibility in Multiple Sclerosis exemplified by a candidate gene search in the CD 28 / CTLA 4 / ICOS gene region

  2005cites this paper
• The polymorphisms −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population

  2005cites this paper
• Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152)

  2004cites this paper
• Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.

  2004cites this paper
• Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

  2004cites this paper
• Multiple Sklerose: potenzielle Therapieansätze und Update laufender Studien

  2004cites this paper
• Demyelinating diseases Neutralizing antibodies to beta-IFN: implications forMSmanagement Review:Neutralizingantibodies to interferonbeta: implications for the management of multiple sclerosis (pp 241–246)

  2004cites this paper
• Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.

  2004influential citation
• Genomic profiling of interpopulation diversity guides prioritization of candidate-genes for autoimmunity

  2004cites this paper
• Genetics of multiple sclerosis.

  2004cites this paper
• The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.

  2004cites this paper
• [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

  2004cites this paper
• Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) gene polymorphism and susceptibility to non‐Hodgkin's lymphoma

  2004cites this paper
• A two-stage study on multiple sclerosis susceptibility and chromosome 2q33

  2004cites this paper
• Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.

  2004cites this paper
• Genes, environment, and susceptibility to multiple sclerosis.

  2004cites this paper
• Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.

  2003cites this paper
• Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q

  2003cites this paper
• Genetic interaction of CTLA‐4 with HLA‐DR15 in multiple sclerosis patients

  2003cites this paper
• Genetic analysis of multiple sclerosis.

  2003cites this paper
• GENETIC ASSOCIATION OF CATALASE AND ANTIGEN PROCESSING GENES WITH VITILIGO SUSCEPTIBILITY

  2003cites this paper
• Genetics of uveitis.

  2003cites this paper
• Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies

  2003cites this paper